UBS Group’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
155,410
+60,133
| +63% | +$718K | ﹤0.01% | 3891 |
|
|
2025
Q1 | $1.13M | Buy |
95,277
+49,096
| +106% | +$584K | ﹤0.01% | 4098 |
|
|
2024
Q4 | $710K | Buy |
46,181
+15,213
| +49% | +$234K | ﹤0.01% | 4476 |
|
|
2024
Q3 | $347K | Buy |
30,968
+1,921
| +7% | +$21.5K | ﹤0.01% | 4328 |
|
|
2024
Q2 | $157K | Sell |
29,047
-22,974
| -44% | -$124K | ﹤0.01% | 4716 |
|
|
2024
Q1 | $354K | Sell |
52,021
-1,510
| -3% | -$10.3K | ﹤0.01% | 4329 |
|
|
2023
Q4 | $363K | Buy |
53,531
+13,958
| +35% | +$94.8K | ﹤0.01% | 4205 |
|
|
2023
Q3 | $198K | Sell |
39,573
-3,988
| -9% | -$20K | ﹤0.01% | 4285 |
|
|
2023
Q2 | $315K | Buy |
43,561
+11,023
| +34% | +$79.8K | ﹤0.01% | 4161 |
|
|
2023
Q1 | $275K | Buy |
32,538
+275
| +0.9% | +$2.32K | ﹤0.01% | 4128 |
|
|
2022
Q4 | $273K | Sell |
32,263
-5,000
| -13% | -$42.4K | ﹤0.01% | 4153 |
|
|
2022
Q3 | $386K | Buy |
37,263
+35,157
| +1,669% | +$364K | ﹤0.01% | 3579 |
|
|
2022
Q2 | $27K | Sell |
2,106
-3,446
| -62% | -$44.2K | ﹤0.01% | 5474 |
|
|
2022
Q1 | $59K | Sell |
5,552
-17,455
| -76% | -$185K | ﹤0.01% | 5307 |
|
|
2021
Q4 | $258K | Buy |
23,007
+2,621
| +13% | +$29.4K | ﹤0.01% | 4449 |
|
|
2021
Q3 | $362K | Buy |
20,386
+1,330
| +7% | +$23.6K | ﹤0.01% | 3911 |
|
|
2021
Q2 | $364K | Buy |
19,056
+4,650
| +32% | +$88.8K | ﹤0.01% | 3955 |
|
|
2021
Q1 | $305K | Buy |
14,406
+1,505
| +12% | +$31.9K | ﹤0.01% | 4236 |
|
|
2020
Q4 | $205K | Buy |
12,901
+7,498
| +139% | +$119K | ﹤0.01% | 4265 |
|
|
2020
Q3 | $30K | Buy |
5,403
+5,397
| +89,950% | +$30K | ﹤0.01% | 5129 |
|
|
2020
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 7076 |
|
|
2020
Q1 | $0 | Sell |
6
-2,938
| -100% | – | ﹤0.01% | 7013 |
|
|
2019
Q4 | $14K | Buy |
2,944
+2,813
| +2,147% | +$13.4K | ﹤0.01% | 6010 |
|
|
2019
Q3 | $1K | Buy |
+131
| New | +$1K | ﹤0.01% | 6848 |
|